Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

September’s top news stories

Novartis signed an agreement to sell parts of its Sandoz US business to Aurobindo Pharma USA for $900m, and the California Department of Insurance filed a lawsuit against AbbVie for allegedly giving illegal kickbacks to healthcare providers to keep prescribing its rheumatoid arthritis drug Humira. Pharmaceutical-technology.com wraps up the key news headlines from September 2018.

Go Top